1. Fentanyl trade: Some members of the House Select Committee on the CCP are forming a working group to address China's role in the fentanyl crisis as part of a more aggressive push to cut off supplies, Axios' Ivana Saric reports.
2. Bayer lobbying: The biotech giant persuaded House Republicans to insert language in the farm bill that could insulate the company from lawsuits alleging that its weedkiller Roundup causes cancer, WaPo reports.
3. Cheaper GLP-1s: Manufacturers in India and China are poised to produce lower-cost versions of blockbuster weight-loss drugs like Wegovy now that patents are running out, Nature reports.
4. Eli Lilly lawsuits: The drugmaker sued six more entities, including medical spas and wellness centers, for selling products claiming to contain the active ingredient in its diabetes drug Mounjaro, per Reuters.
